Φορτώνει......
The Epithelial Barrier Model Shows That the Properties of VSL#3 Depend from Where it is Manufactured
BACKGROUND: VSL#3 has been extensively investigated and is currently recommended for the prevention and treatment of chronic pouchitis and ulcerative colitis. Nonetheless, in vitro and in vivo stud-ies have recently shown variability in the VSL#3 efficacy often attributed to the manufacturing proces...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Endocr Metab Immune Disord Drug Targets |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Bentham Science Publishers
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6425067/ https://ncbi.nlm.nih.gov/pubmed/30360752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1871530318666181022164505 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|